International Partnerships & Global Standards at Concord Guangzhou
August 17, 2026
Guangzhou Concord Cancer Center was developed under the guidance of MD Anderson, collaborates remotely with Mayo Clinic and follows JCI, NCCN and CSCO standards — bringing international cancer-care standards to patients.
Built to International Standards from Day One
Guangzhou Concord Cancer Center belongs to Concord Healthcare Group (listed in Hong Kong). From its founding, the center aimed to bring international cancer-care standards to patients at home and across the region.
A highlight is that its proton center was developed under the guidance of MD Anderson Cancer Center — one of the world's leading cancer centers in the United States.
An International Collaboration Network
- MD Anderson Cancer Center: guidance on building and training for proton therapy.
- Mayo Clinic: collaboration through a telemedicine consultation network.
- Connections to experts and treatment experience from the world's leading centers.
Following Global Treatment Guidelines
Concord's care quality rests on recognized international standards:
- Operates to JCI (Joint Commission International) standards.
- Protocols follow NCCN (US) and CSCO (China) guidelines.
- Led by leading experts in proton radiotherapy and medical physics.
What It Means for International Patients
For patients, international partnerships and global standards bring reassurance: treatment plans built on the most current guidelines, controlled quality processes, and access to world-leading cancer knowledge right here in South China.
Related Images
